Kiernan T. DeAngelis
Director Técnico/Científico/I+D en Humacyte Global, Inc. .
Perfil
Kiernan T.
DeAngelis is currently the Chief Medical Officer at Humacyte Global, Inc. Prior to this, he served as the Global Medical Director at AstraZeneca PLC from 2017 to 2019 and as the Senior Medical Director at United Therapeutics Corp.
from 2013 to 2017.
He also previously held the position of Chief Medical Officer at Humacyte, Inc. from 2020 to 2021.
Dr. DeAngelis completed his undergraduate degree at North Carolina State University and obtained his doctorate from Brody School of Medicine.
Cargos activos de Kiernan T. DeAngelis
| Empresas | Cargo | Inicio |
|---|---|---|
Humacyte Global, Inc.
 Humacyte Global, Inc. Medical SpecialtiesHealth Technology Humacyte Global, Inc. engages in the manufacture of human acellular matrix products for vascular and non-vascular applications. It offers its products to the cardiovascular, cosmetic, soft tissue reconstruction, neurosurgical, and orthopedic markets. The company was founded by Laura E. Niklason, Juliana L. Blum and Shannon L. M. Dahl in 2004 and is headquartered in Durham, NC. | Director Técnico/Científico/I+D | 01/04/2020 |
Antiguos cargos conocidos de Kiernan T. DeAngelis.
| Empresas | Cargo | Fin |
|---|---|---|
| HUMACYTE, INC. | Director Técnico/Científico/I+D | 01/10/2021 |
| ASTRAZENECA PLC | Director Técnico/Científico/I+D | 01/09/2019 |
| UNITED THERAPEUTICS CORPORATION | Director Técnico/Científico/I+D | 01/05/2017 |
Formación de Kiernan T. DeAngelis.
| Brody School of Medicine | Doctorate Degree |
| North Carolina State University | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 3 |
|---|---|
| HUMACYTE, INC. | Health Technology |
| ASTRAZENECA PLC | Health Technology |
| UNITED THERAPEUTICS CORPORATION | Health Technology |
| Empresas privadas | 1 |
|---|---|
Humacyte Global, Inc.
Humacyte Global, Inc. Medical SpecialtiesHealth Technology Humacyte Global, Inc. engages in the manufacture of human acellular matrix products for vascular and non-vascular applications. It offers its products to the cardiovascular, cosmetic, soft tissue reconstruction, neurosurgical, and orthopedic markets. The company was founded by Laura E. Niklason, Juliana L. Blum and Shannon L. M. Dahl in 2004 and is headquartered in Durham, NC. | Health Technology |
- Bolsa de valores
- Insiders
- Kiernan T. DeAngelis